Assis DN, Hov JR(2025) Phase 2 Clinical Trials in Primary Sclerosing Cholangitis: Making the Most of Every Opportunity? J Hepatol(in press) DOI 10.1016/j.jhep.2025.10.022, PubMed 41197906
Kaarbø M, Yang M, Meyer-Myklestad MH, Sundaram AYM, de Sousa MML, Sharma A, Medhus AW, Dyrhol-Riise AM, Kvale D, Hov JR, Aukrust P, Bjørås M, Reikvam DH(2025) Transcriptomic and proteomic profiling reveal immune and metabolic dysregulation in the colonic mucosa of people living with HIV with incomplete immune recovery Front Immunol, 16, 1635523 DOI 10.3389/fimmu.2025.1635523, PubMed 41041301
Mahdy AKH, Schöpfel V, Huppertz-Hauss G, Perminow G, Tran F, Bang C, Hov JR, Bengtson MB, Ricanek P, Opheim R, Aabrekk TB, Detlie TE, Kristensen VA, Poyet M, Høivik ML, Franke A, ElAbd H(2025) Simultaneous profiling of the blood and gut T and B cell repertoires in Crohn's disease and symptomatic controls illustrates tissue-specific alterations in the immune repertoire of individuals with Crohn's disease Front Immunol, 16, 1638522 DOI 10.3389/fimmu.2025.1638522, PubMed 40977727
